Inventiva Sa
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat … Read more
Inventiva Sa (IVA) - Total Assets
Latest total assets as of June 2025: $178.52 Million USD
Based on the latest financial reports, Inventiva Sa (IVA) holds total assets worth $178.52 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Inventiva Sa - Total Assets Trend (2013–2024)
This chart illustrates how Inventiva Sa’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Inventiva Sa - Asset Composition Analysis
Current Asset Composition (December 2024)
Inventiva Sa's total assets of $178.52 Million consist of 93.7% current assets and 6.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 81.2% |
| Accounts Receivable | $12.16 Million | 10.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $48.00K | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Inventiva Sa's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inventiva Sa's current assets represent 93.7% of total assets in 2024, an increase from 18.6% in 2013.
- Cash Position: Cash and equivalents constituted 81.2% of total assets in 2024, up from 15.5% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 10.2% of total assets.
Inventiva Sa Competitors by Total Assets
Key competitors of Inventiva Sa based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Inventiva Sa - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Inventiva Sa generates 0.08x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Inventiva Sa is currently not profitable relative to its asset base.
Inventiva Sa - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.95 | 0.59 | 2.39 |
| Quick Ratio | 2.95 | 0.59 | 2.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $113.92 Million | $ -19.54 Million | $ 34.97 Million |
Inventiva Sa - Advanced Valuation Insights
This section examines the relationship between Inventiva Sa's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.10 |
| Latest Market Cap to Assets Ratio | 3.98 |
| Asset Growth Rate (YoY) | 71.0% |
| Total Assets | $118.97 Million |
| Market Capitalization | $473.78 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Inventiva Sa's assets at a significant premium ( 3.98x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Inventiva Sa's assets grew by 71.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Inventiva Sa (2013–2024)
The table below shows the annual total assets of Inventiva Sa from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $118.97 Million | +71.03% |
| 2023-12-31 | $69.56 Million | -40.04% |
| 2022-12-31 | $116.00 Million | -4.90% |
| 2021-12-31 | $121.98 Million | -12.19% |
| 2020-12-31 | $138.92 Million | +143.89% |
| 2019-12-31 | $56.96 Million | -28.63% |
| 2018-12-31 | $79.81 Million | +7.32% |
| 2017-12-31 | $74.37 Million | +52.20% |
| 2016-12-31 | $48.86 Million | -19.34% |
| 2015-12-31 | $60.58 Million | -17.17% |
| 2014-12-31 | $73.13 Million | -16.05% |
| 2013-12-31 | $87.12 Million | -- |